A detailed history of Mesirow Institutional Investment Management, Inc. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Mesirow Institutional Investment Management, Inc. holds 800,798 shares of CPRX stock, worth $16.9 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
800,798
Previous 934,234 14.28%
Holding current value
$16.9 Million
Previous $14.5 Million 10.01%
% of portfolio
1.26%
Previous 1.32%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$15.19 - $21.35 $2.03 Million - $2.85 Million
-133,436 Reduced 14.28%
800,798 $15.9 Million
Q2 2024

Aug 02, 2024

BUY
$14.68 - $16.92 $3.16 Million - $3.64 Million
215,130 Added 29.92%
934,234 $14.5 Million
Q1 2024

May 06, 2024

BUY
$13.18 - $17.11 $9.48 Million - $12.3 Million
719,104 New
719,104 $11.5 Million

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.17B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Mesirow Institutional Investment Management, Inc. Portfolio

Follow Mesirow Institutional Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Institutional Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Institutional Investment Management, Inc. with notifications on news.